Immunospecific suppression of encephalitogenic-activated T lymphocytes by chimeric cytotoxin IL-2-PE40
- 1 April 1991
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 133 (2) , 379-389
- https://doi.org/10.1016/0008-8749(91)90112-o
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The role of interleukin 2 in autoimmunityImmunology Today, 1989
- Experimental autoimmune encephalomyelitis in “low” and “high” interleukin 2 producer ratsCellular Immunology, 1989
- Vaccination against experimental autoimmune encephalomyelitis using a subencephalitogenic dose of autoimmune effector cells (1) characteristics of vaccinationJournal of Autoimmunity, 1989
- Immunotherapy of experimental autoimmune encephalomyelitis (EAE): Differential effect of anti-IL-2 receptor antibody therapy on actively induced and T-line mediated EAE of the Lewis ratJournal of Autoimmunity, 1989
- Interleukin-2 receptor expression in peripheral blood lymphocytes from systemic lupus erythematosus patients: Relationship to clinical activityClinical Immunology and Immunopathology, 1988
- Cellular immune reactivity within the CNSTrends in Neurosciences, 1986
- In Situ Characterization of Autoimmune Phenomena and Expression of HLA Molecules in the Pancreas in Diabetic InsulitisNew England Journal of Medicine, 1985
- Immunospecific inhibition of nerve conduction by T lymphocytes reactive to basic protein of myelinNature, 1983
- Suppressor cells in Lewis rats with experimental allergic encephalomyelitis: Prevention of the disease and inhibition of lymphocyte proliferation by the suppressor cells or their productsEuropean Journal of Immunology, 1982
- The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitisEuropean Journal of Immunology, 1981